>College of Medicine and SALSA
The Southern Arizona Limb Salvage Alliance (SALSA) at the University of Arizona College of Medicine is dedicated to amputation prevention and healing in persons with diabetes. Its mission is to advance current knowledge regarding assessment and treatment of the diabetic foot and its related diseases/complications, which include ulceration, infection, peripheral vascular disease, neuropathic arthropathy and amputation.
Furthermore, the alliance assesses the impact of these maladies on society and, commensurately, the impact of potential treatments or assessment techniques. SALSA seeks to deliver practical clinical solutions to clinicians and their patients in the developed and developing world.
OmegaGenesis, Inc., is a nanotechnology company based in California and Minnesota. The company is the market innovator in nanotechnology-based angiogenesis and imaging solutions. Its solutions promote the growth of new blood vessels where needed to improve human health.
The company was founded in 2008 to bring Mayo Clinic-proprietary nanomaterial technology to the marketplace. The technology and products are based on the idea that controlling blood-vessel growth will improve human body management for a diverse set of medical applications, ranging from common wound healing to tissue reactivation.
OmegaGenesis is the pioneer in using nutrient enhancement through new capillary growth to heal wounds and activate dormant cells. Its research has led to production of nano-scale materials that work on the cellular and sub-cellular level to promote or inhibit angiogenesis, the growth of new blood vessels.
The company's mission emphasizes collaborative research in partnership with leading medical centers, rapid product design, development and validation. OmegaGenesis collaborates witPage: 1 2 3 4 Related biology technology :1
. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award2
. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco3
. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices4
. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University5
. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine6
. University of Leicester scientists discover technique to help friendly bacteria7
. MichBio Announces Student Career Day at Michigan State University8
. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board9
. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement10
. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor11
. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples